Forbes

A strong emergency plan does more than prepare for one scenario. Learn how families can build backup plans for communication, transportation, medical needs and care.

FDA-approved daraxonrasib targets RAS in metastatic pancreatic cancer, doubling median survival versus chemotherapy and delivering a long-awaited treatment advance.

Why calling OBBBA a “$1 trillion Medicaid cut” misses the bigger story: spending still rises, while the law trims a rapidly growing baseline.

Twenty-five years after 9/11, America’s public health preparedness gaps remain. Protecting the nation requires sustained investment before the next crisis.

With 28 million cosmetic procedures done in 2024, dermatology has never been more crowded. Here's how to separate proven treatments from hype.

NYT says Sen. Roger Marshall sued 700+ patients for unpaid OB-GYN bills. Patient harm is real—and so is the squeeze on independent practices.

Healthcare technology fragmented the patient experience. AI may help reconnect clinicians, medical information and patients while restoring the human side of care.

A public health expert explains how the Trump administration cancelling 16 minority health grants could adversely impact public health.

Startup Inspiren is using AI and sensors to keep residents in assisted living and memory care healthier and out of the ER.

Pharmacy benefit manager reforms through regulatory and legislative actions are weaker than promised. Furthermore, PBMs will likely adapt by finding new revenue streams.

College freshmen encounter campus food environments mirroring America's. Students often prioritize taste over nutrition, despite healthier alternatives being available.

A son reflects on his physician father’s legacy and how it influenced his thinking on the business of healthcare.

It’s safe to that Brian Baumgartner—who played Kevin Malone on The Office—likes golf. He co-hosts the golf podcast “We Need a Fourth“ But he can find it to be a pain.

RevMed’s Rasonque may show our greatest medical advances may become products that society celebrates but increasing numbers of patients cannot obtain.

Independent, peer-reviewed data, rather than a press release alone, remain essential for a complete and accurate understanding of a product's efficacy and safety.